HAPPE Spine, an emerging company focused on improving clinical outcomes through its proprietary biomaterial and manufacturing platform for bone-integrating implants, has announced that its INTEGRATE-C Interbody Fusion System has now been used in over 1,000 patients. The milestone highlights the growing adoption of the HAPPE platform by more than 30 surgeons across 40 medical facilities nationwide.

Health Technology Insights: HOPE Therapeutics Starts ONE-D Depression Treatment

Dr. George S. Naseef, MD, President of the Advanced Spine Center and Interim-Chairman of the Department of Orthopedic Surgery at Morristown Medical Center in New Jersey, praised the system, stating, “The HAPPE INTEGRATE-C has exceeded my expectations. I am seeing faster fusion and higher success rates compared to 3D-printed metal implants, especially in multilevel cases. Post-operative imaging is clear of metal artifacts, and the device fits securely in the disc space, offering more stability than the PEEK implants I have previously used.”

Health Technology Insights: AtaiBeckley Reports Positive BPL-003 Phase 2b Results

Earlier this year, HAPPE Spine completed an oversubscribed bridge funding round to further validate the INTEGRATE-C clinically and expand manufacturing capabilities to support commercial growth and upcoming products. The funding will help the company scale production and accelerate development of future implant solutions.

Additionally, HAPPE Spine successfully completed the MedTech Innovator 2025 Accelerator Cohort, one of only 65 companies selected from nearly 1,500 applicants, placing it in the top 4 percent globally. MedTech Innovator is the world’s largest accelerator for medical technology startups, with over 700 alumni companies that have collectively raised more than $10 billion in follow-on funding and brought over 500 products to market.

Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 10 November 2025

To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com